221 related articles for article (PubMed ID: 11576913)
1. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia?
Nishizawa Y; Shoji T; Ishimura E; Inaba M; Morii H
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S4-7. PubMed ID: 11576913
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.
Suliman ME; Stenvinkel P; Bárány P; Heimbürger O; Anderstam B; Lindholm B
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S89-95. PubMed ID: 12612961
[TBL] [Abstract][Full Text] [Related]
3. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.
Kalantar-Zadeh K; Block G; Humphreys MH; Kopple JD
Kidney Int; 2003 Mar; 63(3):793-808. PubMed ID: 12631061
[TBL] [Abstract][Full Text] [Related]
4. [Renal insufficiency is an important cardiovascular risk factor].
Pérez Flores I; Luño J
Nefrologia; 2002; 22(4):306-9. PubMed ID: 12369120
[No Abstract] [Full Text] [Related]
5. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
[TBL] [Abstract][Full Text] [Related]
6. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
Pawlaczyk K; Oko A; Lindholm B; Czekalski S
Pol Merkur Lekarski; 2003 Oct; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
[TBL] [Abstract][Full Text] [Related]
7. Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
De Vriese AS; Verbeke F; Schrijvers BF; Lameire NH
Kidney Int; 2002 Apr; 61(4):1199-209. PubMed ID: 11918726
[TBL] [Abstract][Full Text] [Related]
8. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
9. Clinical epidemiology in chronic uremia.
Parfrey PS
Clin Invest Med; 1994 Oct; 17(5):466-73. PubMed ID: 7867252
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors].
Collado S; Coll E; Deulofeu R; Guerrero L; Pons M; Cruzado JM; de la Torre B; Vera M; Azqueta M; Nicolau C; Cases A
Nefrologia; 2010; 30(3):342-8. PubMed ID: 20514101
[TBL] [Abstract][Full Text] [Related]
11. Approaches to the reversal of malnutrition, inflammation, and atherosclerosis in end-stage renal disease.
Caglar K; Hakim RM; Ikizler TA
Nutr Rev; 2002 Nov; 60(11):378-87. PubMed ID: 12462522
[TBL] [Abstract][Full Text] [Related]
12. Predialysis management and predictors for early mortality in uremic patients who die within one year after initiation of dialysis therapy.
Biesenbach G; Hubmann R; Janko O; Schmekal B; Eichbauer-Sturm G
Ren Fail; 2002 Mar; 24(2):197-205. PubMed ID: 12071593
[TBL] [Abstract][Full Text] [Related]
13. The cholesterol paradox is flawed; cholesterol must be lowered in dialysis patients.
Wan RK; Mark PB; Jardine AG
Semin Dial; 2007; 20(6):504-9. PubMed ID: 17991195
[TBL] [Abstract][Full Text] [Related]
14. Why do we need a statin trial in hemodialysis patients?
Fellström BC; Holdaas H; Jardine AG
Kidney Int Suppl; 2003 May; (84):S204-6. PubMed ID: 12694345
[TBL] [Abstract][Full Text] [Related]
15. Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis.
Sreedhara R; Avram MM; Blanco M; Batish R; Avram MM; Mittman N
Am J Kidney Dis; 1996 Dec; 28(6):937-42. PubMed ID: 8957050
[TBL] [Abstract][Full Text] [Related]
16. Impact of aortic stiffness on survival in end-stage renal disease.
Blacher J; Guerin AP; Pannier B; Marchais SJ; Safar ME; London GM
Circulation; 1999 May; 99(18):2434-9. PubMed ID: 10318666
[TBL] [Abstract][Full Text] [Related]
17. Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia.
Avram MM; Sreedhara R; Avram DK; Muchnick RA; Fein P
Am J Kidney Dis; 1996 Dec; 28(6):924-30. PubMed ID: 8957048
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease and the renal transplant recipient.
Kendrick E
Am J Kidney Dis; 2001 Dec; 38(6 Suppl 6):S36-43. PubMed ID: 11729004
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.
Suliman ME; Qureshi AR; Bárány P; Stenvinkel P; Filho JC; Anderstam B; Heimbürger O; Lindholm B; Bergström J
Kidney Int; 2000 Apr; 57(4):1727-35. PubMed ID: 10760109
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
